drugset / Trial / NCT05035654
LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study)
RandomizedParallel-groupSingle-blindTreatment
Summary
This study will assess the safety, tolerability, pharmacokinetics and efficacy of two LYR-220 designs in symptomatic adult chronic rhinosinusitis (CRS) subjects who have had a prior functional endoscopic sinus surgery.
Timeline
- Start
- 2021-11-23
- Primary completion
- 2023-08-30
- Completion
- 2023-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mometasone furoate | Other / unclassified | 7500 ug | Other |